A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF

Clinical trial NCT00765050 · TERMINATED

Trial details

NCT number: NCT00765050
Sponsor: PETHEMA Foundation
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetic Patients With Critic Ischemia in Lower Limbs Who Are Administered With CD133+ Cells Mobilized by G-CSF

Start date: 2009-01-01
Primary completion: 2012-10-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.